What Does Europe’s Biggest Oncology Congress Mean for the Wider World?

Pre-emptive Medicine in Cardiometabolic Renal Disease

Rare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 4: Prasanna Shirol (Co-founder & Director of ORDI)

Rare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 3: Prof. Dave Pearce (Chair of the IRDiRC)

Rare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 2: Michelle Werner (CEO at Alltrna, CEO-Partner at Flagship Pioneering)

Rare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 1: Dr. John Brandsema MD (Children’s Hospital of Philadelphia)

Companion Diagnostics: In-house vs. Partnerships - What’s the Winning Formula?

Axiom Crossroads: Go-to-Market Strategies

Axiom Crossroads: Industry at a Crossroads

Axiom Crossroads: Best Foot Forward

Axiom Crossroads: Between Oncology and Rare Diseases

Axiom Crossroads: Reimagining Clinical Trials

Axiom Crossroads: CEO & Founder Spotlight

Axiom Crossroads: Innovation Where It Is Needed Most

Axiom Crossroads: Partnering for Innovation with Paul Biondi

Gynecologic Cancer Awareness Month Special 2024

Bladder Cancer Awareness Month 2024

Gynecologic Cancer Awareness Month Special

Duchenne Muscular Dystrophy: Dr. Han Phan on the changing treatment landscape

ALS Awareness Month: Dr Tim Williams on ALS/MND from physician’s perspective